Net Income
Net income attributable to common stock
CME Group Net income attributable to common stock remained flat by 0.0% to $1.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $944.20M to $1.17B. Over 4 years (FY 2021 to FY 2025), Net income attributable to common stock shows an upward trend with a 11.3% CAGR.
Analysis
StatementIncome Statement
SectionNet Income
First reportedQ1 2019
Last reportedQ1 2026Apr 24, 2026
Metric ID:
t_net_income_attributable_to_common_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $510.30M | $926.50M | $605.90M | $702.00M | $654.10M | $671.10M | $630.00M | $872.70M | $767.80M | $740.80M | $804.30M | $844.40M | $872.10M | $901.30M | $863.70M | $944.20M | $1.01B | $896.60M | $1.17B | $1.17B |
| QoQ Change | — | +81.6% | -34.6% | +15.9% | -6.8% | +2.6% | -6.1% | +38.5% | -12.0% | -3.5% | +8.6% | +5.0% | +3.3% | +3.3% | -4.2% | +9.3% | +7.2% | -11.4% | +30.3% | +0.0% |
| YoY Change | — | — | — | — | +28.2% | -27.6% | +4.0% | +24.3% | +17.4% | +10.4% | +27.7% | -3.2% | +13.6% | +21.7% | +7.4% | +11.8% | +16.1% | -0.5% | +35.2% | +23.7% |
Range$510.30M – $1.17B
CAGR+19.0%
Avg YoY Growth+13.1%
Median YoY Growth+14.8%
Current Streak2 quarters growth
Net income attributable to common stock at Other Companies
Frequently Asked Questions
- What is CME Group's net income attributable to common stock?
- CME Group (CME) reported net income attributable to common stock of $1.17B in Q1 2026.
- How has CME Group's net income attributable to common stock changed year-over-year?
- CME Group's net income attributable to common stock increased by 23.7% year-over-year, from $944.20M to $1.17B.
- What is the long-term trend for CME Group's net income attributable to common stock?
- Over 4 years (2021 to 2025), CME Group's net income attributable to common stock has grown at a 11.3% compound annual growth rate (CAGR), from $2.62B to $4.02B.